Key result
Identification of high-risk patients using major clinical risk factors and subsequent prevention of sudden cardiac death with an implantable cardioverter-defibrillator is a mainstay of care in hypertrophic cardiomyopathy.
This review outlines the risk factors for sudden cardiac death in hypertrophic cardiomyopathy and emphasizes the role of ICDs in primary and secondary prevention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Václav Durdil (2010) conducted a review in Hypertrophic cardiomyopathy. Implantable cardioverter-defibrillator (ICD) was evaluated. Identification of high-risk patients using major clinical risk factors and subsequent prevention of sudden cardiac death with an implantable cardioverter-defibrillator is a mainstay of care in hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: